Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Pharma symbols : Atrs save search
Halozyme Completes Antares Pharma Acquisition
Published: 2022-05-24 (Crawled : 13:20) - biospace.com/
HALO 4 | $38.4 -0.83% -0.83% 640K
|
Health Technology
|
| O: -0.61%
H: 2.5%
C: 1.72%
acquisition pharma
Halozyme to Acquire Antares Pharma to Create a Specialty Product and Drug Delivery Leader
Published: 2022-04-13 (Crawled : 11:00) - biospace.com/
HALO 4 | $38.4 -0.83% -0.83% 640K
|
Health Technology
|
| O: 0.29%
H: 1.2%
C: -0.67%
ATRS | $5.59 0.0%
|
Health Technology
|
| O: 48.53%
H: 0.63%
C: 0.45%
pharma drug
Antares Pharma Announces FDA Approval Of TLANDO™, an Oral Treatment for Testosterone Replacement Therapy Commercial launch expected in 2Q 2022
Published: 2022-03-29 (Crawled : 21:00) - biospace.com/
ATRS | $5.59 0.0%
|
Health Technology
|
| O: 0.48%
H: 0.87%
C: -1.45%
treatment fda pharma approval therapy commercialization
Antares Pharma Reports Fourth Quarter and Full-Year 2021 Financial and Operating Results
Published: 2022-03-03 (Crawled : 20:00) - biospace.com/
ATRS | $5.59 0.0%
|
Health Technology
|
| O: 4.52%
H: 6.21%
C: 2.7%
report results pharma
Antares Pharma to Present at the Cowen 42nd Annual Healthcare Conference
Published: 2022-02-28 (Crawled : 20:00) - biospace.com/
ATRS | $5.59 0.0%
|
Health Technology
|
| O: -0.57%
H: 1.73%
C: 0.86%
health thc conference pharma
Antares Pharma To Report Fourth Quarter And Full-Year 2021 Financial And Operating Results
Published: 2022-02-17 (Crawled : 14:00) - biospace.com/
ATRS | $5.59 0.0%
|
Health Technology
|
| O: -0.55%
H: 0.55%
C: -1.65%
report results pharma
Antares Pharma Receives FDA Fast Track Designation for ATRS-1902 for Adrenal Crisis Rescue
Published: 2022-01-18 (Crawled : 13:00) - biospace.com/
ATRS | $5.59 0.0%
|
Health Technology
|
| O: 0.9%
H: 0.0%
C: -4.24%
atrs-1902 fast track designation fda fast track renal fda fast track designation pharma
Antares Pharma Announces Positive Results From Phase I Study For ATRS-1902 For Adrenal Crisis Rescue
Published: 2022-01-11 (Crawled : 13:00) - biospace.com/
ATRS | $5.59 0.0%
|
Health Technology
|
| O: -0.29%
H: 0.0%
C: 0.0%
positive pharma
Antares Pharma Announces Divestiture of Otrexup®
Published: 2021-12-15 (Crawled : 23:00) - globenewswire.com
ASRT | $0.7975 -2.08% -2.12% 590K
|
Health Technology
|
| O: 4.44%
H: 21.28%
C: 18.44%
ATRS | $5.59 0.0%
|
Health Technology
|
| O: 0.92%
H: 1.89%
C: -0.91%
otrexup trex pharma
Antares Pharma to Participate in the Piper Sandler 33rd Annual Virtual Healthcare Conference
Published: 2021-11-22 (Crawled : 13:00) - globenewswire.com
ATRS | $5.59 0.0%
|
Health Technology
|
| O: 2.31%
H: 1.13%
C: -3.39%
conference pharma
Antares Pharma to Present at the Jefferies London Healthcare Conference
Published: 2021-11-10 (Crawled : 17:00) - globenewswire.com
ATRS | $5.59 0.0%
|
Health Technology
|
| O: -1.29%
H: 1.57%
C: -1.31%
conference pharma
Antares Pharma Announces Appointment of Carmen Volkart to its Board of Directors
Published: 2021-10-28 (Crawled : 14:00) - biospace.com/
ATRS | $5.59 0.0%
|
Health Technology
|
| O: 0.57%
H: 2.86%
C: 1.14%
pharma
Antares Pharma Announces Oral Presentation at the 22nd Annual Fall Scientific Meeting of SMSNA
Published: 2021-10-25 (Crawled : 13:00) - globenewswire.com
ATRS | $5.59 0.0%
|
Health Technology
|
| O: -0.4%
H: 0.67%
C: -1.08%
presentation pharma
Antares Pharma to Report Third Quarter 2021 Financial and Operating Results
Published: 2021-10-21 (Crawled : 13:00) - globenewswire.com
ATRS | $5.59 0.0%
|
Health Technology
|
| O: 0.0%
H: 3.83%
C: 2.46%
results pharma
Lipocine And Antares Pharma Enter Into U.S. Licensing Agreement To Commercialize TLANDO®
Published: 2021-10-18 (Crawled : 19:00) - biospace.com/
LPCN | $5.355 -10.46% 37K
|
Health Technology
|
| O: 10.62%
H: 0.0%
C: -5.6%
ATRS | $5.59 0.0%
|
Health Technology
|
| O: -1.16%
H: 4.11%
C: 3.81%
license commercialization pharma
Antares Pharma Initiates Phase I Study For ATRS-1902 For Adrenal Crisis RescuePharmacokinetic data results expected in 1Q 2022
Published: 2021-09-30 (Crawled : 19:00) - biospace.com/
ATRS | $5.59 0.0%
|
Health Technology
|
| O: 0.55%
H: 0.27%
C: -1.09%
renal results pharma
Antares Pharma to Participate in the H.C. Wainwright 23rd Annual Global Investment Conference
Published: 2021-09-08 (Crawled : 14:00) - globenewswire.com
ATRS | $5.59 0.0%
|
Health Technology
|
| O: -0.76%
H: 0.76%
C: -2.54%
conference pharma
Antares Pharma Reports Second Quarter 2021 Financial and Operating Results
Published: 2021-08-05 (Crawled : 12:00) - biospace.com/
ATRS | $5.59 0.0%
|
Health Technology
|
| O: -1.88%
H: 2.87%
C: 1.2%
results pharma
Antares Pharma to Report Second Quarter 2021 Financial and Operating Results
Published: 2021-07-28 (Crawled : 13:00) - globenewswire.com
ATRS | $5.59 0.0%
|
Health Technology
|
| O: 0.46%
H: 2.5%
C: 1.59%
results pharma
Antares Pharma Announces FDA Acceptance of IND Application for ATRS-1902 for Adrenal Crisis Rescue
Published: 2021-07-22 (Crawled : 13:00) - globenewswire.com
ATRS | $5.59 0.0%
|
Health Technology
|
| O: -0.45%
H: 1.12%
C: -2.47%
fda fda acceptance renal application pharma
Gainers vs Losers
| 58% | 42% |
Top 10 Gainers
WISA 4 | $6.06 246.29% 71.12% 200M
|
Electronic Technology
VIAO | $0.265 -13.96% 35.85% 960K
|
Electronic Technology
JAGX | $0.178 49.83% 33.26% 600M
|
Health Technology
SXTC | $1.68 43.59% 30.36% 34M
|
Health Technology
DYNT | $0.531 43.36% 30.24% 22M
|
Health Technology
KA | $0.4796 41.06% 29.11% 5.3M
|
Manufacturing
PALI | $5.86 40.87% 29.01% 29M
|
Manufacturing
CLNN | $0.319 -3.74% 28.75% 6.3M
|
BSGM | $1.52 38.18% 27.63% 3.3M
|
Health Technology
MCBC | $13.67 37.66% 27.36% 2.2M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.